WALTHAM, Mass., Feb. 3, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that it will release its financial results for the fourth quarter, ended December 31, 2014. The Company will host a conference call beginning at 8:30 a.m. ET on Tuesday, February 10, 2015, to discuss these results and provide business updates.
The conference call and accompanying slide presentation will be webcast live on the Investor Relations section of Alere's website or accessed directly through the following link: http://www.videonewswire.com/event.asp?id=101458.
To access the conference call, please use the following dial-in numbers and access code 9692678:
US (toll-free): 1-888-317-6003
International: 1-412-317-6061
Canada (toll-free): 1-866-284-3684
A replay will be available approximately one hour after the conclusion of the call and will remain available for a period of seven days following the call. To hear a replay of the conference call, please use the following dial-in numbers and replay code 10059719 (available for seven days):
US (toll-free): 1-877-344-7529
International: 1-412-317-0088
Canada (toll-free): 855-669-9658
The replay will also be available via online webcast at http://www.videonewswire.com/event.asp?id=101458 or via the Alere website at http://www.alere.com/us/en/about/investor-relations/events.html for a period of 60 days following the call.
During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.
About Alere
Because Knowing now matters™, Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.
SOURCE Alere Inc.
Share this article